Cargando…
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors
Childhood neuroblastic tumors are characterized by heterogeneous clinical courses, ranging from benign ganglioneuroma (GN) to highly lethal neuroblastoma (NB). Although a refined prognostic evaluation and risk stratification of each tumor patient is becoming increasingly essential to personalize tre...
Autores principales: | Veschi, V, Petroni, M, Bartolazzi, A, Altavista, P, Dominici, C, Capalbo, C, Boldrini, R, Castellano, A, McDowell, H P, Pizer, B, Frati, L, Screpanti, I, Gulino, A, Giannini, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973198/ https://www.ncbi.nlm.nih.gov/pubmed/24603328 http://dx.doi.org/10.1038/cddis.2014.68 |
Ejemplares similares
-
Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells
por: Veschi, Veronica, et al.
Publicado: (2012) -
Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours
por: Uccini, S, et al.
Publicado: (2006) -
Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status
por: Giannini, G, et al.
Publicado: (2000) -
Molecular mechanisms of MYCN-dependent apoptosis and the MDM2–p53 pathway: an Achille’s heel to be exploited for the therapy of MYCN-amplified neuroblastoma
por: Petroni, Marialaura, et al.
Publicado: (2012) -
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs
por: Capalbo, Carlo, et al.
Publicado: (2019)